Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.680
+0.020 (1.20%)
At close: Jan 16, 2026, 4:00 PM EST
1.710
+0.030 (1.79%)
After-hours: Jan 16, 2026, 4:00 PM EST
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $3.39 million as of January 16, 2026. Its market cap has decreased by -0.25% in one year.
Market Cap
3.39M
Enterprise Value
2.59M
1-Year Change
-0.25%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since June 21, 2019, Artelo Biosciences's market cap has decreased from $12.30M to $3.39M, a decrease of -72.43%. That is a compound annual growth rate of -17.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 3.40M | 36.00% |
| Dec 31, 2025 | 2.50M | -26.47% |
| Dec 31, 2024 | 3.40M | -24.44% |
| Dec 29, 2023 | 4.50M | -45.78% |
| Dec 30, 2022 | 8.30M | -62.27% |
| Dec 31, 2021 | 22.00M | 100.00% |
| Dec 31, 2020 | 11.00M | 18.28% |
| Dec 31, 2019 | 9.30M | -24.39% |
| Jun 21, 2019 | 12.30M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |